Harvest Fund Management Co. Ltd Has $137,000 Stake in Encompass Health Co. (NYSE:EHC)

Harvest Fund Management Co. Ltd reduced its stake in Encompass Health Co. (NYSE:EHC) by 64.1% during the third quarter, HoldingsChannel reports. The firm owned 1,415 shares of the company’s stock after selling 2,527 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in Encompass Health were worth $137,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in EHC. UMB Bank n.a. lifted its stake in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC grew its stake in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares during the last quarter. Oakworth Capital Inc. bought a new position in shares of Encompass Health in the 2nd quarter valued at $40,000. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health during the 3rd quarter valued at $40,000. Finally, Benjamin F. Edwards & Company Inc. grew its position in Encompass Health by 58.9% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after acquiring an additional 198 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Trading Down 0.9 %

NYSE EHC opened at $102.84 on Thursday. The stock has a market capitalization of $10.36 billion, a P/E ratio of 24.84, a P/E/G ratio of 1.35 and a beta of 0.88. The business has a 50 day simple moving average of $97.53 and a 200 day simple moving average of $91.11. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a one year low of $63.78 and a one year high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.86 EPS. Research analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a $0.17 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. Encompass Health’s dividend payout ratio is presently 16.43%.

Analysts Set New Price Targets

A number of brokerages have recently commented on EHC. Royal Bank of Canada lifted their price target on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. KeyCorp upped their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Barclays lifted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Stephens restated an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a report on Tuesday, August 6th. Finally, UBS Group upped their price target on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.